openPR Logo
Press release

Chikungunya Fever Drugs Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027

03-14-2022 09:11 AM CET | Health & Medicine

Press release from: Orion Market Research

The global chikungunya fever drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Chikungunya is a mosquito borne viral disease caused by the RNA virus belonging to the alphavirus genus of family Togaviridae. Its transmission from human to human is facilitated by the bites of infected female mosquitoes. The prevalence of chikungunya fever has been reported in more than 60 countries of Asia, Africa, Europe and the Americas, to date. Most commonly, the genus of mosquitoes responsible for the cause of the disease include Aedes aegypti and Aedes albopictus. Presently, there is no cure for the disease, although the treatments are focused only to address the symptoms. In 2019, according to the World Health Organization, 349 936 suspected and 146 914 laboratory confirmed cases of chikungunya were reported to the PAHO regional office. Countries that reported the most cases were Brazil (265,000 suspected cases), Bolivia and Colombia (19,000 suspected cases, respectively).

To Request a Sample of our Report on Chikungunya Fever Drugs Market: https://www.omrglobal.com/request-sample/chikungunya-fever-drugs-market

Further, in September 2019, according to the European Centre for Disease Prevention and Control, there were about 102 autochthonous chikungunya cases in Italy. Such trends for chikungunya fever were seen across the region. This is expected to boost the market growth during the forecasted period. Growing geriatric population coupled with the poor hygienic conditions are the major concerns that increase the risk factor for chikungunya. Additionally, the increasing R&D investments by the key market players are likely to provide a boost to the global chikungunya fever drugs market during the forecast period. Moreover, the increasing government investments and favorable policies will fuel the market.

Market Coverage

· The market number available for - 2020-2027

· Base year- 2020

· Forecast period- 2021-2027

Segment Covered-

· By Product Type

· By End-User

Regions covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape: Abivax SA, Merck & Co. Inc., and Bharat Biotech International Ltd., among others.

(Get 15% Discount on Buying this Report)

A full Report of Chikungunya Fever Drugs Market is Available @ https://www.omrglobal.com/industry-reports/chikungunya-fever-drugs-market

Global Chikungunya Fever Drugs Market Report by Segment

By Product Type

• Vaccine

• Monoclonal Antibodies

• Synthetic Peptides

• Others

By End-User

• Hospitals

• Clinics

• Others

Global Chikungunya Fever Drugs Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chikungunya Fever Drugs Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027 here

News-ID: 2577298 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for Chikungunya

Chikungunya market is expected to reach USD 1.4 billion by 2034
Chikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV), transmitted primarily by Aedes aegypti and Aedes albopictus. The infection is characterized by sudden high fever, severe joint pain, rash, headache, and fatigue. While rarely fatal, chikungunya often leads to chronic arthritis-like symptoms lasting months to years, creating a significant burden on healthcare systems. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71953 Global spread is accelerating due to
Chikungunya Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportu …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Projected Growth of the Chikungunya Market? In recent times, there has been robust growth in the chikungunya market size. It is projected to expand from $0.59 billion in 2024 to $0.65 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. Factors that have contributed to this
Chikungunya Pipeline Insight 2025: 10+ Advancing Therapies and Key Companies in …
The therapeutic landscape for Chikungunya, a viral disease transmitted by mosquitoes that causes severe joint pain, fever, and rash, is rapidly evolving, fueled by advancements in antiviral research and vaccine development. Leading biopharmaceutical companies such as Valneva, Moderna Therapeutics, Themis Bioscience, FIT Biotech, Bharat Biotech, and Emergex Vaccines are at the forefront of developing innovative therapies, targeting various stages of the virus lifecycle, immune modulation, and pain management to alleviate
Chikungunya Fever Global Clinical Trials Review, H2, 2018: Researchmoz.us
Researchmoz added Most up-to-date research on "Chikungunya Fever Global Clinical Trials Review, H2, 2018" to its huge collection of research reports. An insight on the important factors and trends influencing the market. Latest clinical trial report, Chikungunya Fever Global Clinical Trials Review, H2, 2018" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview
Chikungunya Fever Market Segmentation 2018 with Recent Trend by 2023
Chikungunya Fever Market - Highlights Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash. There is
Chikungunya Fever Market Worldwide Segmentation with Top Key Merchant – Avail …
Chikungunya Fever Market - Highlights Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash. There is